A Randomized Control Trial to Assess Early Clinical and Functional Outcome of the ROCC and LCS Total Knee Implant Designs
A Prospective Randomized Study on Early Clinical and Functional Outcome of the ROCC and LCS Total Knee Arthroplasty Implant Designs
1 other identifier
interventional
200
1 country
1
Brief Summary
This is a prospective Randomised Control Trial to compare the Early Clinical and Functional Outcome of the ROCC and LCS total knee arthroplasty implant designs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 17, 2008
CompletedFirst Posted
Study publicly available on registry
September 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedJune 20, 2017
June 1, 2017
3.8 years
September 17, 2008
June 16, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
American Knee Society Score
Preoperative, 8weeks, 1 year
Secondary Outcomes (2)
WOMAC
preoperative, 8 weeks, 1 year
VAS Pain
Preoperative, 4weeks, 8weeks, 3months, 1 year
Study Arms (2)
1
EXPERIMENTALROCC
2
ACTIVE COMPARATORLCS
Interventions
Eligibility Criteria
You may qualify if:
- Patients suitable for cementless knee replacement
- Patients skeletally mature and under 80 years of age at pre-operative clinic
- Patients presenting with osteoarthritis of the knee
- Patients must be ambulatory at time of pre-operative clinic
- Patients must be able to understand instructions and be will to return for follow-up
You may not qualify if:
- Previous knee surgery (except arthroscopic/open menisectomy)
- Patients with inflammatory arthritis
- Patients with significant medical co-morbidity - ASA IV
- Disorders causing abnormal gait or significant pain
- Patients unable to consent
- Severe visual impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
- Biomet U.K. Ltd.collaborator
Study Sites (1)
Musgrave Park Hospital
Belfast, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2008
First Posted
September 18, 2008
Study Start
April 1, 2007
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
June 20, 2017
Record last verified: 2017-06